I don't expect any major news to drop in the company...

  1. 4,803 Posts.
    lightbulb Created with Sketch. 14840
    I don't expect any major news to drop in the company presentation/webinar on Wednesday.

    but we have been told it will "provide an operational update and discuss near-term opportunities for the business."

    who doesn't want to hear news about that?

    just from the 2 interviews last week we got these

    7 CET partnerships still going strong


    Screenshot 2025-02-24 at 5.42.04 pm.png

    expansion into the North American market

    Screenshot 2025-02-24 at 5.46.03 pm.png

    life science team, will be in india in a week or so. vidcare partnership looks strong. increased sensitivity and decreased costs

    Screenshot 2025-02-24 at 5.47.17 pm.png

    10 more life science companies in India

    Screenshot 2025-02-24 at 5.48.23 pm.png

    also talk of e-mobility and ev's in india

    Screenshot 2025-02-24 at 6.15.07 pm.png


    also some interesting points on cycle requirements, cathodes, electrolytes and cost per kilowatt hour.

    if you believe it or not is up to each investor.

    plus the detailed financials are always worth a read

    and just with Ultranode. who's electrolyte are we using? is there a chemical company anteotech has been dealing with the last 18 months? Hmmm!!!

    as I said looking forward to Wednesday

    GLTAH
    Last edited by captainblood: 24/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.002(18.2%)
Mkt cap ! $35.16M
Open High Low Value Volume
1.1¢ 1.3¢ 1.1¢ $35.38K 2.922M

Buyers (Bids)

No. Vol. Price($)
3 400000 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 936650 4
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.